TNFSF10 and neoplasm: On the other hand, as suggested by others, the overexpression of ligands of the TNF-family such as FasL and TRAIL may be associated with immunological advantages for tumour cells by counterattacking tumour infiltrating cytotoxic lymphocytes [41-43].